First in a series.  On Dec. 11, after I had spent more than 80% of 2020 at home, the door to normalcy cracked open. That day, the U.S. Food and Drug Administration authorized the Pfizer-BioNTech COVID-19 vaccine for emergency use. Being an immunocompromised transplant patient with Crohn’s, I fall into Phase 1C, as defined by the U.S. Centers for Disease Control and Prevention (CDC). This group includes people ages 16 to 64 with underlying medical…

You must be logged in to read/download the full post.